股价暴跌60%!某疫苗制造商 2024年的下滑之路及扭转局势的计划

谈思生物
18 Dec 2024

2024.12.18本文字数:1712,阅读时长大约4分钟导读:面对后疫情时代的挑战,Moderna股价今年已下跌超60%。尽管计划在2028年前削减高达40亿美元研发支出,投资者仍不看好其短期盈利前景。后疫情时代对新冠疫苗制造商Moderna的经济形势并不乐观,这家位于剑桥的生物科技公司正面临一系列挑战,导致其股价今年迄今已下跌超过60%。Seeking Alpha的一项新分析显示,尽管...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10